Delivery Order SPE2DB22D2007-SPE2DB24FJ3DQ
Award Date 6/6/24
Potential Completion Date 6/7/24
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $14,004.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,565,094,188 units of the HAVRIX 1,440 unit/mL syringe medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. The IDC allows the DLA to efficiently procure a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,567.92 firm fixed price delivery order to provide 4,563,580,840 units of the HAVRIX 720 0.5 ML syringe. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,423.56 Firm Fixed Price Delivery Order is for the supply of 4,567,893,721 units of the HAVRIX 1,440 unit/mL syringe medication. The contract has an ultimate completion date of April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $8,753.04 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,981,944 units of the HAVRIX 720 Unit/0.5 ML syringe 0.5ML pharmaceutical product. The delivery order has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical products. The contract is a Delivery Order with a firm fixed price of $1,582.66 and an ultimate completion date of July 11, 2025. The award was made by the Defense Logistics Agency (DLA), a defense agency, on July 10, 2025. The contract is not set aside and is for open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,642.43 firm fixed-price delivery order is for the supply of 4,568,249,523 units of the HAVRIX 1,440 UNIT/ML SYRINGE medication. The contract has an ultimate completion date of May 15, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.55 firm fixed-price contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medication, with a completion date of June 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,899.75 firm fixed-price delivery order is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of 4,564,529,550 units of HAVRIX 1,440 UNIT/ML SYRINGE/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The Firm Fixed Price contract, valued at $2,758.38, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. The contract has an ultimate completion date of May 8, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,716.50 firm-fixed-price delivery order is for the supply of 1,440 units/ml of the HAVRIX vaccine. The contract has an ultimate completion date of July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of prescription medications, over-the-counter drugs, and...